Compare · HIMS vs TALK
HIMS vs TALK
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Talkspace Inc. (TALK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and TALK operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 7.9x TALK ($870.6M).
- HIMS has hit the wire 9 times in the past 4 weeks while TALK has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 15 for TALK).
- Company
- Hims & Hers Health Inc.
- Talkspace Inc.
- Price
- $28.05-4.54%
- $5.25+0.00%
- Market cap
- $6.85B
- $870.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2020
- News (4w)
- 9
- 0
- Recent ratings
- 25
- 15
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Talkspace Inc.
Talkspace Inc. operates as a virtual behavior healthcare company. It delivers healthcare through encrypted web and mobile platform. The company offers treatment options for every need, including psychiatry or adolescent, individual, or couples therapy. The members can send text, video, and voice messages to their therapists and engage in live video sessions. The company is based in New York, New York.
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)
Latest TALK
- SEC Form 15-12G filed by Talkspace Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Talkspace Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Talkspace Inc.
- Chief Financial Officer Harris Ian Jiro returned 724,805 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Executive Officer Cohen Jon R returned 2,841,807 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Technology Officer Margolin Gil returned 267,013 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Chief Marketing Officer Watson Katelyn returned 390,222 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Abbott Swati Bargotra returned 171,696 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Benzur Liat returned 156,276 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Director Yeaney Jacqueline E returned 356,832 shares to the company, closing all direct ownership in the company (SEC Form 4)